86 related articles for article (PubMed ID: 3125022)
1. Prostacyclin prevents hyperacute xenogenous rejection of the kidney.
Heller J; Horácek V
Czech Med; 1987; 10(4):195-200. PubMed ID: 3125022
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandins activation of erythropoietin production and erythroid progenitor cells.
Fisher JW; Radtke HW; Jubiz W; Nelson PK; Burdowski A
Exp Hematol; 1980; 8 Suppl 8():65-89. PubMed ID: 6761139
[TBL] [Abstract][Full Text] [Related]
3. Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin.
Mundy AR; Bewick M; Moncada S; Vane JR
Prostaglandins; 1980 Apr; 19(4):595-603. PubMed ID: 6992233
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.
Susić H; Malik KU
J Pharmacol Exp Ther; 1981 Sep; 218(3):588-92. PubMed ID: 6167710
[TBL] [Abstract][Full Text] [Related]
5. Influence of the PG-analogues iloprost, nalador and nileprost on rejection time and TXB2 content of murine tail skin allografts.
Becker K; Lueddeckens G; von Baehr R; Förster W
Biomed Biochim Acta; 1988; 47(10-11):S117-20. PubMed ID: 2470350
[TBL] [Abstract][Full Text] [Related]
6. Effect of a stable prostacyclin analogue on canine renal allograft rejection.
Tobimatsu M; Ueda Y; Toyoda K; Saito S; Konomi K
Ann Surg; 1987 Feb; 205(2):199-202. PubMed ID: 3545109
[TBL] [Abstract][Full Text] [Related]
7. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
Konturek SJ
Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
[No Abstract] [Full Text] [Related]
8. Enhanced prostacyclin synthesis in acute human kidney transplant rejection.
Leithner C; Sinzinger H; Silberbauer K; Wolf A; Stummvoll HK; Pinggera W
Proc Eur Dial Transplant Assoc; 1980; 17():424-8. PubMed ID: 7017684
[TBL] [Abstract][Full Text] [Related]
9. [Blood flow measurements with 133xenon during prolonged hyperacute xenogenic rejection].
Schmidt KR; Pfeifer KJ; Chaussy C; Hammer C; Krebs G; Heinze HG
Strahlentherapie Sonderb; 1975; 74():211-9. PubMed ID: 1105901
[No Abstract] [Full Text] [Related]
10. Morphologic study of the participation of the complement system in hyperacute rejection of renal xenotransplants.
Mejĩa-Laguna JE; Martĩnez-Palomo A; Biro CE; Chãvez B; Lõpez-Soriano F; Carcĩa-Cornejo M
Am J Pathol; 1972 Oct; 69(1):71-8. PubMed ID: 4562798
[TBL] [Abstract][Full Text] [Related]
11. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
[TBL] [Abstract][Full Text] [Related]
12. Effect of prostacyclin and glycoprotein IIb/IIIa inhibitor on hyperacute rejection in a rabbit-to-dog lung xenotransplant model.
Onozuka N; Harada O; Kobayashi M; Suto T; Fukuda A; Sudo Y; Takaya S
Transplant Proc; 2003 Feb; 35(1):531-2. PubMed ID: 12591518
[No Abstract] [Full Text] [Related]
13. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.
Dosekun AK; First MR; Chandran PK; Kant KS; Glas-Greenwalt P; Weiss MA; Alexander JW; Pollak VE
Clin Nephrol; 1982 Aug; 18(2):101-5. PubMed ID: 6754189
[TBL] [Abstract][Full Text] [Related]
14. [Experimental evaluation of prostacyclin for preventing hyperacute rejection in cross-species heterotopic heart transplantation].
Kasahara K; Zhao HX; Aziz S; Jamieson S; Shumway N; Tatsumi A; Kagawa T
Nihon Kyobu Geka Gakkai Zasshi; 1986 Jul; 34(7):966-71. PubMed ID: 3534114
[No Abstract] [Full Text] [Related]
15. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
Ito S; Camussi G; Tetta C; Milgrom F; Andres G
Lab Invest; 1984 Aug; 51(2):148-61. PubMed ID: 6379289
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
[No Abstract] [Full Text] [Related]
17. Release of prostaglandin I2 from hog kidney by propranolol.
Gotoh S; Ogihara T; Ohde H; Nakamaru M; Masuo K; Saeki S; Kumahara Y
Prostaglandins Leukot Med; 1982 Jun; 8(6):537-44. PubMed ID: 7051046
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal and cardiovascular effects of the prostaglandin analogue Hoe 260.
Bickel M; Bartmann W; Beck G; Lerch U; Schleyerbach R; Schölkens BA
Biomed Biochim Acta; 1984; 43(8-9):S235-8. PubMed ID: 6596097
[TBL] [Abstract][Full Text] [Related]
19. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
20. Role of a prostaglandin E1 analogue in the prevention of acute graft rejection by cyclosporine.
N Engl J Med; 1990 Sep; 323(12):831-3. PubMed ID: 2118233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
